| Financial Year |
March 31 2023 |
| Monetary Funds |
839,392,400.29 |
| Held-for-trading Financial Assets |
479,834.74 |
| Notes Receivable |
117,334,054.46 |
| Accounts Receivable |
3,479,580,800.50 |
| Advances to Suppliers |
289,426,693.83 |
| Other Receivables |
757,278,500.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,180,532,700.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
61,394,136.80 |
| Other Current Assets |
44,623,563.04 |
| Total Current Assets |
6,792,909,390.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
611,483,753.66 |
| Investment Properties |
800,026,405.51 |
| Fixed Assetes |
1,164,974,242.82 |
| Under-construction Projects |
270,211,842.05 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
761,232,976.04 |
| R&D expenses |
209,205,120.27 |
| Goodwill |
17,223,922.78 |
| Long-Term Deferred and Prepaid Expenses |
17,385,872.93 |
| Deferred Income Tax Assets |
257,877,582.31 |
| Other Non-Current Assets |
559,691,587.03 |
| Sub-Total of Non-Current Assets |
5,282,193,697.61 |
| Total Assets |
12,075,103,088.03 |
| Short-Term Loans |
1,446,330,083.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
27,600,331.87 |
| Accounts Payable |
787,701,257.78 |
| Accounts Received In Advance |
96,010.60 |
| Employee Compensation Payable |
27,860,424.52 |
| Taxes Payable |
222,340,545.53 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
388,084,697.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
457,467,202.64 |
| Other Current Liabilities |
53,810,235.56 |
| Sub-Total of Current Liabilities |
3,454,888,708.77 |
| Long-term Loans |
1,020,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,014,770.65 |
| Other Non-Current Liabilities |
46,392,996.17 |
| Sub-Total of Non-Current Liabilities |
1,259,168,157.05 |
| Total Liabilities |
4,714,056,865.82 |
| Paid-In Capital(Or Share Stock) |
941,963,592.00 |
| Capital Surplus |
2,349,596,891.07 |
| Surplus Reserve |
470,981,796.00 |
| LESS:Treasury Stock |
29,994,441.51 |
| Undistributed Profits |
3,617,083,819.07 |
| Minority Stockholder's Interest |
8,335,548.25 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,352,710,673.96 |
| Owner's Equity（Stockholder's Equity） |
7,361,046,222.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,075,103,088.03 |
